Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 19408-84-5
2. 6,7-dihydrocapsaicin
3. N-(4-hydroxy-3-methoxybenzyl)-8-methylnonanamide
4. 8-methyl-n-vanillylnonanamide
5. Dihydro Capsaicin
6. Nonanamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-
7. N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnonanamide
8. Chebi:46932
9. Nonanamide, 8-methyl-n-vanillyl-
10. 8-methyl Dihydrocapsaicin
11. 8-methyl-n-vanillyl-nonanamide
12. N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methylnonanamide
13. W9bv32m08a
14. Nonanamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-
15. Tnp00314
16. Ccris 1589
17. Sr-01000075976
18. Brn 2815150
19. Unii-w9bv32m08a
20. Dihydrocapsacine
21. Mfcd00057794
22. Dihydrocapsaicin,(s)
23. Lopac-m-1022
24. Capsaicin, Dihydro-
25. Lopac0_000782
26. Ccris1589
27. Mls002153458
28. Schembl119080
29. Chembl311158
30. Dtxsid4041864
31. Dihydrocapsaicin [usp-rs]
32. Hms2232l10
33. Hms3262m06
34. Hms3371m21
35. Hms3649n17
36. Bcp09851
37. Hy-n0361
38. Zinc2522581
39. Dihydrocapsaicin, Analytical Standard
40. Tox21_500782
41. Bdbm50231198
42. Stl570272
43. Zb1859
44. Akos016009558
45. Ccg-204867
46. Lp00782
47. Sdccgsbi-0050760.p002
48. Ncgc00015645-01
49. Ncgc00015645-02
50. Ncgc00015645-03
51. Ncgc00015645-04
52. Ncgc00015645-05
53. Ncgc00015645-06
54. Ncgc00015645-13
55. Ncgc00094119-01
56. Ncgc00094119-02
57. Ncgc00094119-03
58. Ncgc00261467-01
59. Ac-23369
60. As-77558
61. Smr001230817
62. Db-044848
63. Cs-0008911
64. Eu-0100782
65. Ft-0624952
66. N1679
67. S9086
68. Dihydrocapsaicin, From Capsicum Sp., >=85%
69. A14534
70. C16952
71. M 1022
72. 408d845
73. Q-100236
74. Q5276422
75. Sr-01000075976-1
76. Sr-01000075976-6
77. Dihydrocapsaicin (constituent Of Capsicum) [dsc]
78. N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-nonanamide
79. N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnonenamide
80. Dihydrocapsaicin, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 307.4 g/mol |
|---|---|
| Molecular Formula | C18H29NO3 |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 10 |
| Exact Mass | 307.21474379 g/mol |
| Monoisotopic Mass | 307.21474379 g/mol |
| Topological Polar Surface Area | 58.6 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 307 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
98
PharmaCompass offers a list of Dihydrocapsaicin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dihydrocapsaicin manufacturer or Dihydrocapsaicin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dihydrocapsaicin manufacturer or Dihydrocapsaicin supplier.
PharmaCompass also assists you with knowing the Dihydrocapsaicin API Price utilized in the formulation of products. Dihydrocapsaicin API Price is not always fixed or binding as the Dihydrocapsaicin Price is obtained through a variety of data sources. The Dihydrocapsaicin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dihydrocapsaicin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydrocapsaicin, including repackagers and relabelers. The FDA regulates Dihydrocapsaicin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydrocapsaicin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dihydrocapsaicin supplier is an individual or a company that provides Dihydrocapsaicin active pharmaceutical ingredient (API) or Dihydrocapsaicin finished formulations upon request. The Dihydrocapsaicin suppliers may include Dihydrocapsaicin API manufacturers, exporters, distributors and traders.
Dihydrocapsaicin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydrocapsaicin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydrocapsaicin GMP manufacturer or Dihydrocapsaicin GMP API supplier for your needs.
A Dihydrocapsaicin CoA (Certificate of Analysis) is a formal document that attests to Dihydrocapsaicin's compliance with Dihydrocapsaicin specifications and serves as a tool for batch-level quality control.
Dihydrocapsaicin CoA mostly includes findings from lab analyses of a specific batch. For each Dihydrocapsaicin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydrocapsaicin may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydrocapsaicin EP), Dihydrocapsaicin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydrocapsaicin USP).
